Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 142.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 706.00
  • 52 Week Low: 130.00
  • Currency: UK Pounds
  • Shares Issued: 4.73m
  • Volume: 0
  • Market Cap: £6.74m
  • RiskGrade: 340
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £267,511
Vladislav Sandler Ph.D. 103,862 £148,003
Peter Redmond 13,991 £19,937

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £267,511
Dr Vladislav Sandler 103,862 £148,003
Optiva Securities Limited 70,329 £100,219
Flascherberg Capital Anstalt 69,991 £99,737
Craig Auringer 59,593 £84,920
HSBC Client Holdings Nominee (UK) Limited 45,160 £64,353
Ron Valk 42,828 £61,030
Samantha Bauer 42,706 £60,856
Plum Capital 29,232 £41,656
43 North LLC 28,429 £40,511
Abdelatif LACHAB 6,500 £9,262
Wayne Gibson 6,500 £9,262

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 142.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 706.00
52 Week Low 130.00
Volume 0
Shares Issued 4.73m
Market Cap £6.74m
Beta 0.00
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.94% below the market average46.94% below the market average46.94% below the market average46.94% below the market average46.94% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average
Price Trend
94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average
91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page